Data / Form D filings / CORNERSTONE THERAPEUTICS INC
CORNERSTONE THERAPEUTICS INC: Form D filing
CORNERSTONE THERAPEUTICS INC, a pharmaceuticals company in Cary, NC, filed a Form D with the SEC in 2012. The latest, on July 3, 2012, reports $30 million sold of a $30 million offering to 1 investor.
Find out what CORNERSTONE THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1255 CRESCENT GREEN DRIVE, SUITE 250, Cary, NC, 27518
- Phone
- (919) 678-6611
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1145404
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 3, 2012 | New notice | $30,000,000 | $30,000,000 | $0 | 1 | Jun 21, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MARCO M. VECCHIA | Director | |
| ALAN T. ROBERTS | Executive Officer | |
| CRAIG A. COLLARD | Executive Officer, Director | |
| MICHAEL D. ENRIGHT | Director | |
| MICHAEL A. HEFFERNAN | Director | |
| KENNETH R. MCBEAN | Executive Officer | |
| LAURA D. SHAWVER | Director | |
| ROBERT M. STEPHAN | Director | |
| ANTON GIORGIO FAILLA | Director | |
| CHRISTOPHER G. CODEANNE | Director | |
| VINCENT T. MORGUS | Executive Officer | |
| JAMES A. HARPER | Director | |
| ANDREW K. W. POWELL | Executive Officer |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Jul 2, 2012 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CORNERSTONE THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.